Business
Anti-inflammatory drug may shorten COVID-19 recovery time – Sydney Morning Herald
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalised COVID-19 patients shortens their time to recovery by an additional day.
Lilly said it planned to discuss with regulators the possible emergency use of baricitinib for hospitalised COVID-19 patients.
It would be important to know how many study participants also received steroid drugs, which have been shown in other research to lower the risk of death for severely ill, hospitalised COVID-19 patients, said Dr Jesse Goodman, former US Food and Drug Administration chief scientist now at Georgetown University who had no role in the study.
Figuring out how to best use t…
-
Noosa News23 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
General22 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
Noosa News24 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
General22 hours agoTruck driver charged with causing death by dangerous driving after highway crash